Literature DB >> 10754523

Ornithine decarboxylase activity and its gene expression are increased in benign hyperplastic prostate.

X Liu1, L Wang, Y Lin, Q Teng, C Zhao, H Hu, W Chi.   

Abstract

BACKGROUND: Ornithine decarboxylase (ODC) is the first key enzyme in the polyamine biosynthesis pathway. Polyamine is believed to participate in cellular proliferation and differentiation. To study the relationship between ODC and the pathogenesis of benign prostatic hyperplasia (BPH), the polyamine levels, ODC activities, and expression of ODC mRNA in benign hyperplastic and normal human prostates were assayed.
METHODS: Polyamine contents and ODC activities in tissue extracts were determined by reverse-phase high-performance liquid chromatography and spectrophotometric procedures, respectively. The ODC mRNA levels were assayed by Northern blot analysis.
RESULTS: The contents of putrescine, spermidine, and spermine in BPH tissues were 2.2, 3.4, and 6.0 times higher than those in normal tissues, respectively; the ODC activity of BPH tissue was about 3.2 times higher than in normal tissue; the expression level of ODC mRNA in the BPH tissues was greater than that of normal tissues.
CONCLUSIONS: The findings imply that 1) the increased ODC activity and polyamine content in prostatic tissue may correlate with the pathogenesis of BPH, and 2) the high level of ODC activity is induced by the overexpression of ODC mRNA. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754523     DOI: 10.1002/(sici)1097-0045(20000501)43:2<83::aid-pros2>3.0.co;2-o

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  5 in total

1.  Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus.

Authors:  Wei Wang; Bin Jin; Wei Li; Chun-Xiao Xu; Fu-Ai Cui; Bin Liu; Yun-Fei Yan; Xian-Xi Liu; Xiu-Li Wang
Journal:  Mol Biol Rep       Date:  2009-10-30       Impact factor: 2.316

2.  Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.

Authors:  Dipak S Pisal; Venkata K Yellepeddi; Ajay Kumar; Radhey S Kaushik; Michael B Hildreth; Xiangming Guan; Srinath Palakurthi
Journal:  Int J Pharm       Date:  2007-08-26       Impact factor: 5.875

3.  The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia.

Authors:  Katherine J O'Malley; Rajiv Dhir; Joel B Nelson; James Bost; Yan Lin; Zhou Wang
Journal:  Prostate       Date:  2009-12-01       Impact factor: 4.104

4.  Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.

Authors:  Carissa F Santos; John Kurhanewicz; Z Laura Tabatabai; Jeffry P Simko; Kayvan R Keshari; Akpene Gbegnon; Romelyn Delos Santos; Scot Federman; Katsuto Shinohara; Peter R Carroll; Christopher M Haqq; Mark G Swanson
Journal:  NMR Biomed       Date:  2009-12-23       Impact factor: 4.044

5.  Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy.

Authors:  Basetti Madhu; Greg L Shaw; Anne Y Warren; David E Neal; John R Griffiths
Journal:  Metabolomics       Date:  2016-06-30       Impact factor: 4.290

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.